CAM Guidance Statement On Probiotics Is “Astonishing,” Concerns Experts

FDA's Center for Biologics Evaluation and Research may be laying the groundwork for greater control of the regulation of probiotics in the agency's recently released guidance document on "complementary and alternative medicine products," according to industry stakeholders

More from Archive

More from Pink Sheet